Literature DB >> 16234180

Quality of life in rheumatoid arthritis.

T K Kvien1, T Uhlig.   

Abstract

Assessment of health-related quality of life (HRQoL) is relevant for the patients and is important in both clinical research and daily clinical practice. Generic and disease-specific instruments for assessment of HRQoL are reviewed. Changes in HRQoL provide important information on randomized controlled clinical trials as well as on observational studies. The floor effect is a limitation of many of the scales, especially in patients with less severe disease. Feasibility and low test-retest reproducibility limit the use of many of the instruments in clinical practice, especially when they are used for individual treatment decisions. Electronic transferral of data from patients to the health professionals by, for example, internet or a personal digital assistant (PDA), opens up new opportunities for frequent patient reports and improved access to the data.

Entities:  

Mesh:

Year:  2005        PMID: 16234180     DOI: 10.1080/03009740500327727

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  30 in total

Review 1.  A Bayesian mixed treatment comparison of efficacy of biologics and small molecules in early rheumatoid arthritis.

Authors:  Vincenzo Venerito; Giuseppe Lopalco; Fabio Cacciapaglia; Marco Fornaro; Florenzo Iannone
Journal:  Clin Rheumatol       Date:  2019-01-10       Impact factor: 2.980

Review 2.  Measurement properties of rheumatoid arthritis-specific quality-of-life questionnaires: systematic review of the literature.

Authors:  Jiyeon Lee; Soo Hyun Kim; Seung Hei Moon; Eun-Hyun Lee
Journal:  Qual Life Res       Date:  2014-05-21       Impact factor: 4.147

3.  Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.

Authors:  Merita Qorolli; Blerta Rexhepi; Sylejman Rexhepi; Matej Mustapić; Ines Doko; Simeon Grazio
Journal:  Rheumatol Int       Date:  2019-03-07       Impact factor: 2.631

Review 4.  Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.

Authors:  Jasvinder A Singh; Alomgir Hossain; Amy S Mudano; Elizabeth Tanjong Ghogomu; Maria E Suarez-Almazor; Rachelle Buchbinder; Lara J Maxwell; Peter Tugwell; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

5.  The validity and reliability of the Turkish version of the Rheumatoid and Arthritis Outcome Score (RAOS) in patients with rheumatoid arthritis.

Authors:  Altinay Göksel Karatepe; Rezzan Günaydin; Gül Türkmen; Taciser Kaya; Gülriz Ozbek
Journal:  Clin Rheumatol       Date:  2008-07-30       Impact factor: 2.980

6.  Health-related quality of life in Moroccan patients with rheumatoid arthritis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2012-08-18       Impact factor: 2.980

7.  A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview.

Authors:  Jasvinder A Singh; Robin Christensen; George A Wells; Maria E Suarez-Almazor; Rachelle Buchbinder; Maria Angeles Lopez-Olivo; Elizabeth Tanjong Ghogomu; Peter Tugwell
Journal:  CMAJ       Date:  2009-11-02       Impact factor: 8.262

Review 8.  Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.

Authors:  Jasvinder A Singh; Alomgir Hossain; Elizabeth Tanjong Ghogomu; Amy S Mudano; Lara J Maxwell; Rachelle Buchbinder; Maria Angeles Lopez-Olivo; Maria E Suarez-Almazor; Peter Tugwell; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2017-03-10

Review 9.  Infections With Biologics in Rheumatoid Arthritis and Related Conditions: a Scoping Review of Serious or Hospitalized Infections in Observational Studies.

Authors:  Jasvinder A Singh
Journal:  Curr Rheumatol Rep       Date:  2016-10       Impact factor: 4.592

Review 10.  Quality-of-life assessment in rheumatoid arthritis.

Authors:  Anthony S Russell
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.